NewsFeed
March, 2026
March 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Abhishek Kumar: Next-Gen Insights on Antiphospholipid Syndrome Care
Mar 1, 2026, 16:33

Abhishek Kumar: Next-Gen Insights on Antiphospholipid Syndrome Care

Abhishek Kumar, Lead Analyst at DelveInsight Business Research LLP, shared a post on LinkedIn:

“Next-Gen Antiphospholipid Syndrome Pipeline Insights Transforming Autoimmune Care

Antiphospholipid Syndrome is gaining attention as research shifts from symptom control to precision immunology. Scientists are exploring complement inhibition, B-cell modulation, and targeted biologics to reduce clot risk, inflammation, and pregnancy complications. Growing awareness, improved diagnostics, and expanding clinical trials are accelerating therapeutic innovation. The future of APS care may soon include disease-modifying treatments that address immune mechanisms rather than only preventing thrombosis. Discover how emerging science is reshaping autoimmune management and guiding next-generation treatment strategies for better long-term outcomes and patient quality of life.

Recent developments include, National Institute of Allergy and Infectious Diseases (NIAID) announced result of Targeting CD38 With Daratumumab in Primary Antiphospholipid Syndrome: A Phase 1b Dose Escalation Safety Trial (ITN093AI).

The Antiphospholipid Syndrome Companies include Genentech (Roche), Sanofi, Bristol Myers Squibb, Teva Pharmaceuticals, Pfizer, Novartis, and others.

Learn more about rare disease innovation and next-generation therapies today.”

Stay updated on all scientific advances in the field of fertility with Fertility News.